Yüklüyor......

Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000–2008

BACKGROUND: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in hemophilia patients with inhibitors but has been applied to a wide range of off-label indications. OBJECTIVE: To estimate patterns of off-label rFVIIa use in United States hospitals. DESIGN: Retrospective database...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Logan, Aaron C., Yank, Veronica, Stafford, Randall S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011398/
https://ncbi.nlm.nih.gov/pubmed/21502649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!